What do systematic reviews say?

Intravenous vs oral cyclophosphamide

Intravenous showed no clear difference in relapse at end of study compared with oral cyclophosphamide (low certainty).

• Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 0.99 [0.76, 1.29]
  2 studies · 83 participants
  Low